Tech Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal Jonathan Jeriah November 16, 2022 1 min read Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.Read More About The Author Jonathan Jeriah See author's posts Continue Reading Previous Previous post: ‘We’ve slotted him everywhere else and it hasn’t worked’: Why Huberdeau is on Flames 3rd lineNext Next post: Badenoch Calls for Green Investment to ‘Future-Proof’ UK Economy Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Drexel Morgan Advisors Drives AI Fintech Innovation with Record Capital Raises in 2025 Drexel Morgan Advisors Drives AI Fintech Innovation with Record Capital Raises in 2025 September 25, 2025 Contractor optimism for robots grows, but usage drops Contractor optimism for robots grows, but usage drops September 25, 2025